Biocryst Pharmaceuticals reported $-29582000 in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Alexion Pharmaceuticals ALXN:US $ 816.7M 185.9M
Alnylam Pharmaceuticals ALNY:US $ -146160000 40.09M
Biocryst Pharmaceuticals BCRX:US $ -29582000 21.8M
Chemocentryx CCXI:US $ -38738000 9.41M
Chugai Pharma 4519:JP 96.71B 32.75B
Daiichi Sankyo 4568:JP 45.77B 71.44B
Gilead Sciences GILD:US $ 2262M 639M
GlaxoSmithKline GSK:LN 1.96B 281M
Glaxosmithkline GSK:US 1.96B 281M
Intra Cellular Therapies ITCI:US $ -69141060 15.92M
IONIS PHARMACEUT IONS:US $ -72969000 19M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Mirati Therapeutics MRTX:US $ -164186000 31.76M
Neurocrine Biosciences NBIX:US $ 67.8M 36.3M
Novavax NVAX:US $ -345829000 137.2M
Ptc Therapeutics PTCT:US $ -98493000 345K
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Sarepta Therapeutics SRPT:US $ -167574000 25.71M
Ultragenyx Pharmaceutical RARE:US $ -82776000 23.79M
Vertex Pharmaceuticals VRTX:US $ -36.36M 920.29M
YTE INCY:US $ 155.31M 40.5M
Zogenix ZGNX:US $ -55431000 3.63M